ACCOY’s mission is to develop and commercialize novel NDA approved drug + DTx combination medications that represent new therapies that address significant unmet medical needs while saving on the total cost of care.

BEYOND THE DRUG

REDEFING CARE UTILIZING 

NEW DTX ORAL DRUG THERAPIES

ACCOY drugs utilize ACCOY's broadly applicable patents pending DTx platform technologies, the ACCOY System™, to go beyond the drug to deliver a clinically validated improved measurable clinical outcome. 

Source: Image from Inside DigitalHealth

REDEFING CARE WITH

NEW DTX DRUG THERAPIES